Correlation Between Sk Biopharmaceutica and ISU Abxis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sk Biopharmaceutica and ISU Abxis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sk Biopharmaceutica and ISU Abxis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sk Biopharmaceuticals Co and ISU Abxis Co, you can compare the effects of market volatilities on Sk Biopharmaceutica and ISU Abxis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sk Biopharmaceutica with a short position of ISU Abxis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sk Biopharmaceutica and ISU Abxis.

Diversification Opportunities for Sk Biopharmaceutica and ISU Abxis

0.49
  Correlation Coefficient

Very weak diversification

The 3 months correlation between 326030 and ISU is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Sk Biopharmaceuticals Co and ISU Abxis Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ISU Abxis and Sk Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sk Biopharmaceuticals Co are associated (or correlated) with ISU Abxis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ISU Abxis has no effect on the direction of Sk Biopharmaceutica i.e., Sk Biopharmaceutica and ISU Abxis go up and down completely randomly.

Pair Corralation between Sk Biopharmaceutica and ISU Abxis

Assuming the 90 days trading horizon Sk Biopharmaceuticals Co is expected to generate 0.9 times more return on investment than ISU Abxis. However, Sk Biopharmaceuticals Co is 1.11 times less risky than ISU Abxis. It trades about 0.04 of its potential returns per unit of risk. ISU Abxis Co is currently generating about 0.0 per unit of risk. If you would invest  7,090,000  in Sk Biopharmaceuticals Co on August 28, 2024 and sell it today you would earn a total of  3,000,000  from holding Sk Biopharmaceuticals Co or generate 42.31% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Sk Biopharmaceuticals Co  vs.  ISU Abxis Co

 Performance 
       Timeline  
Sk Biopharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sk Biopharmaceuticals Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
ISU Abxis 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ISU Abxis Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Sk Biopharmaceutica and ISU Abxis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sk Biopharmaceutica and ISU Abxis

The main advantage of trading using opposite Sk Biopharmaceutica and ISU Abxis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sk Biopharmaceutica position performs unexpectedly, ISU Abxis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ISU Abxis will offset losses from the drop in ISU Abxis' long position.
The idea behind Sk Biopharmaceuticals Co and ISU Abxis Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios